RiverVest Venture Partners
Beijing | China
| Investor Type | Firm |
| Type of Fund | Venture Capital Fund |
| Industries | Software (Web Marketplace Saas..) • IT (& TMT) • Media • BioTech • FinTech (& Financials services) • Hardware (& Manufacturing) • Energy • CleanTech • HealthTech (& Fitness) • Material Science • Medical Devices (& Hospital Services) • Life Science • Oncology |
| Stages | Early Stage |
| Investing | U.S.A. • India • China • Singapore • Taiwan • Asia • Indonesia |
| Investment Range | $500,000 - $3,000,000 |
| Assets Under Management | $2,000,000,000 |
About The Fund
RiverVest Venture Partners is a venture capital firm based in Saint Louis, Missouri. The firm invests in companies that operate in the biopharma and medical devices sector.
RiverVest Venture Partners's investments on record
| OncoResponse | ||
| Securus Medical Group | $10,000,000.00 | Later stage VC |
| InterVene | $15,000,000.00 | Later stage VC |
| Venture Med Group | $15,000,000.00 | Later stage VC |
| Flex Vessel Prep | $15,900,000.00 | Later stage VC |
| Adarza BioSystems | $17,000,000.00 | Later stage VC |
| Spruce Biosciences | $20,000,000.00 | Early stage VC |
| Neuros Medical | $22,634,257.00 | Early stage VC |
| Amplyx Pharmaceuticals | $40,500,000.00 | Later stage VC |
32 New Startups
Started their fundraising
over the last 7 days
